Microdosing GLP-1s: What It Is, Who It May Help, and What the Research Shows
By Mace Scott, MD, Founder and Medical Director, Chronos Body Health & Wellness
"Can I just take a small dose?" is one of the most common questions I get about GLP-1 medications. Some patients had nausea on the standard schedule. Some have reached their goal and don't want to stop completely. Others simply want a gentler, less expensive way to use these medications. All of those are reasonable questions, and they deserve a straight answer.
What is GLP-1 microdosing?
Semaglutide and tirzepatide are usually started at a low dose and increased every few weeks until a patient reaches a standard therapeutic dose. "Microdosing" means staying at a lower dose than that standard schedule, and adjusting slowly based on how you respond.
It's important to understand that microdosing is an off-label use of these medications. The FDA-approved doses are the ones that were tested in large clinical trials. Lower-dose plans haven't been studied the same way.
What the research does and doesn't show
At standard doses, GLP-1 medications are some of the best-studied treatments we have. Large trials have shown meaningful weight loss and better blood sugar control, and some GLP-1 medications have shown heart and kidney benefits in people with specific medical conditions.
What we don't know yet is how much of that benefit carries over to much lower doses. You'll see bold claims online that microdosing prevents disease, reverses aging, or protects the brain. The research simply isn't there yet to support those statements, and I don't think patients are well served by pretending otherwise.
What I can tell you from practice is that lower doses are often easier to tolerate, and some patients find a lower dose is enough to keep their appetite in check.
Who might consider a lower-dose approach?
- Patients who had side effects like nausea at standard doses
- Patients who have reached their goal weight and want to discuss a maintenance plan with their provider
- Patients who want a more gradual approach to appetite control
- Patients looking for a lower-cost option than full-dose treatment
It isn't the right fit for everyone. If your goal is significant weight loss, standard dosing has the strongest evidence behind it, and that's usually where I'll steer you.
How we approach it at Chronos
Every patient starts with a full medical evaluation. If a lower-dose plan makes sense, we build it around your history, your goals, and how your body responds, and we follow up regularly to track your progress and any side effects. If a standard dose turns out to fit your goals better, we'll talk about that too.
When compounded medications are part of a plan, they're prescribed only when a provider determines they're medically appropriate for that patient. Compounded medications are not FDA-approved, and we're upfront with patients about that.
The bottom line
Microdosing GLP-1s can be a reasonable option for the right patient, especially for tolerance or maintenance. It isn't a proven prevention strategy, and anyone who promises that is getting ahead of the science. If you're curious whether a lower-dose plan fits your goals, let's talk it through honestly.
Learn more about our low-dose GLP-1 program and medical weight loss options, or contact our Metairie office to schedule a consultation.
Mace Scott, MD is the founder and medical director of Chronos Body Health & Wellness in Metairie, Louisiana. He earned his medical degree and a master's degree from LSU Health Sciences Center and trained in emergency medicine before focusing his practice on hormone therapy, metabolic health, and medical weight loss.
This article is for educational purposes and is not a substitute for individual medical advice. Individual results vary. Treatment decisions are made after a full medical evaluation.
